Kelik, Sulis Suhermin (2020) RASIONALITAS PENGGUNAAN OBAT PADA PASIEN HEPATITIS B YANG MENJALANI RAWAT INAP DI RSUD SOEHADI PRIJONEGORO SRAGEN 2018. Diploma thesis, Sekolah Tinggi Ilmu Kesehatan Nasional.
| ![[img]](http://librepo.stikesnas.ac.id/style/images/fileicons/text.png) | Text Fulltext Kelik Sulis Suhermin.pdf Restricted to Repository staff only Download (3MB) | 
| ![[img]](http://librepo.stikesnas.ac.id/style/images/fileicons/text.png) | Text KTI.pdf Download (927kB) | 
Abstract
Hepatitis B is a hepatitis B virus (HBV) infection in the liver that can be acute or chronic. In previous studies, results showed that therapy without indication of 2 cases (9.5%), the need for additional therapy 18 cases (85.7%), ineffective drugs 4 cases (19.0%), dose too low 5 cases (23.8%), and high dose in 7 cases (33.3%). This study was to determine the characteristics of patients and to find out how to use drugs in hepatitis B patients in inpatients at Soehadi Pridjonegoro Sragen 2018 Hospital according to the exact, right patient, right drug, right dose. The technique used to find samples using non-probability sampling techniques that is, taking samples not based on what can be calculated, but based on mere practicality. The method used is purposive sampling, the sample taken is a sample that has certain criteria from the announced medical record data, age, sex, drug used, treatment dose, laboratory data. Main research results: characteristics based on male sex 77.1%, based on age 56-65 years 31.3%, use of antiviral therapy 7%, supportive therapy 93%, 100% precise indication, 100% right patient, right 100% patients, right drug 95.83%, right dose 100%, rationality of drug use 95.83%.
| Item Type: | Thesis (Diploma) | 
|---|---|
| Subjects: | R Medicine > RN Pharmacy and Pharmaceutical Mathematics | 
| Depositing User: | Unnamed user with email [email protected] | 
| Date Deposited: | 02 Mar 2021 03:53 | 
| Last Modified: | 02 Mar 2021 03:53 | 
| URI: | http://librepo.stikesnas.ac.id/id/eprint/398 | 
Actions (login required)
|  | View Item | 
 
        